Dziękuję dr Magdalenie Żabickiej z Zakładu Radiologii Wojskowego Instytutu Medycznego za udostępnienie dokumentacji radiologicznej.

Piśmiennictwo:

1. Rowińska-Zakrzewska E. Rozstrzenie oskrzeli. w: Choroby układu oddechowego. red. Ewa Rowińska-Zakrzewska i Jan Kuś. Warszawa, Wydawnictwo Lekarskie PZWL 2004:198-204.

2. Smyrnios N. Irwin R., Curley F. Chronic cough with a history of excessive sputum production: the spectrum and frequency of causes and key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995; 108: 991-997.

3. Li A.M., Sonnappa S., Lex C., Wong E., Zacharasiewicz A., Bush A., Jaffe A. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur. Respir. J. 2005; 26(1): 8-14.

4. Lasserson T.J., Holt K., Evans D., Milan S.J., Greenstone M. Anticholinergic therapy for bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

5. Sheikh A., Nolan D., Greenstone M. Long-acting beta2-agonists for bronchiectasis Cochrane Database of Systematic Reviews, Issue 3, 2008.

6. Corless J.A., Warburton C.J. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

7. Steele K., Lasserson J.A., Greenstone M. Oral methylxanthines for bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

8. Crockett A.J., Cranston J.M., Latimer K.M., Alpers J.H. Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

9. Jones A. Wallis C.E., Kearney C.E. Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Systematic Review. Issue 2, 2004.

10. O’Donnell A., Barker A., Ilowite J. i wsp. Treatment of idiopathic bronchiectasis with aerolized recombinant human Dnase. Chest 1998; 113: 1329-1334.

11. Ram F.S.F., Wells A., Kolbe J. Inhaled steroids for bronchiectases. Cochrane Database of Systematic Reviews, Issue 3, 2008.

12. Kapur N., Chang A.B. Oral non steroid anti-inflammatories for children and adults with bronchiectasis. The Cochrane Database of Systematic Reviews, Issue 3, 2008.

13. Evans D.J., Bara A.I., Greenstone M.Prolonged antibiotics for purulent bronchiectasis in children and adults Cochrane Database of Systematic Reviews, Issue 2, 2007.

14. Southern K.W., Barker P.M., Solis A. Macrolide antibiotics for cystic fibrosisCochrane Database of Systematic Reviews, Issue 3, 2008.

15. O’Toole G.A., Kolter R. Flagella and twitching motility are necessary for Pseudmonas aureginosa biofilm development. Mol. Microbiol. 1998; 30: 295-304.

16. Rosen M.J. Chronic cough due to bronchiectasis. ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 122-131.

17. Jones A.P., Rowe B.H. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis Cochrane Database of Systematic Reviews, Issue 3, 2008.

18. Corless J.A., Warburton C.J. Surgery versus non-surgical treatment for bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

19. Chang C.C., Singleton R.J., Morris P.S., Chang A.B. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2008.

20. Chang C.C, Morris P.S., Chang A.B. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews, Issue 3, 2007.